Basic Research
Copyright ©The Author(s) 2005.
World J Gastroenterol. Aug 7, 2005; 11(29): 4519-4523
Published online Aug 7, 2005. doi: 10.3748/wjg.v11.i29.4519
Table 1 Cell cycle distribution of BXPC-3 cells 2 d after IAA plus HRP treatment
TreatmentG1/G0G2/MS
Control62.28±8.340.43±0.5737.28±8.91
40 µmol/L IAA/HRP76.68±5.06a0.85±1.4722.47±5.83
80 µmol/L IAA/HRP76.91±5.78a18.77±1.87a4.32±6.66a
Table 2 SOD activity and MDA content in BXPC-3 cells 3 d after IAA and HRP treatment (mean±SD)
TreatmentControl40 µmol/L80 µmol/L
IAA /HRPIAA/HRP
SOD (nU/mg protein)105.60±41.04135.98±1.46193.34±37.89b
MDA (µmol/L/mg protein)20.80±0.3322.29±1.0499.53±30.45b